Active-ingredient Dossier
Bimatoprost
Active-ingredient Dossier for Bimatoprost (prostaglandin analogue). Australian brands, products, PBS listings, PBAC outcomes — compiled by arcimedes.
- Brand: BIMATOPROST
- Brand: BIMATOPROST
- Brand: BIMATOPROST-WGR
- Brand: BIMPROZT
- Brand: GANFORT
- Brand: BIMATIGAN
- Therapeutic area: Ophthalmology
What is
Bimatoprost Bimatoprost is a prostaglandin analogue.
Australian brands containing
Bimatoprost The following brands contain bimatoprost and are registered on the ARTG: — BIMATOPROST — LUMIGAN — BIMATOPROST-WGR — BIMPROZT — GANFORT — BIMATIGAN — BIMATOLUGAN — BIMTOP — LUMATOGAN — LUMIFOR — LUMIPROST
Therapeutic areas
Bimatoprost is registered in ophthalmology, with 15 brands containing this ingredient on the ARTG.
Sponsor landscape
Five sponsors market bimatoprost in Australia: Arrotex Pharmaceuticals, AbbVie, Sandoz, GM Pharma and Viatris.
PBS and regulatory activity
Two brands containing bimatoprost have PBS-listed items, with the latest PBS schedule date being 1 May 2026. The latest PBAC outcome on record is from 1 July 2020, and no AusPAR has been issued for bimatoprost.